These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11756754)
1. Gene-expression profiles in hereditary breast cancer. Chinnaiyan AM; Rubin MA Adv Anat Pathol; 2002 Jan; 9(1):1-6. PubMed ID: 11756754 [TBL] [Abstract][Full Text] [Related]
2. Gene-expression profiles in hereditary breast cancer. Hedenfalk I; Duggan D; Chen Y; Radmacher M; Bittner M; Simon R; Meltzer P; Gusterson B; Esteller M; Kallioniemi OP; Wilfond B; Borg A; Trent J; Raffeld M; Yakhini Z; Ben-Dor A; Dougherty E; Kononen J; Bubendorf L; Fehrle W; Pittaluga S; Gruvberger S; Loman N; Johannsson O; Olsson H; Sauter G N Engl J Med; 2001 Feb; 344(8):539-48. PubMed ID: 11207349 [TBL] [Abstract][Full Text] [Related]
3. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH. Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA signatures in hereditary breast cancer. Murria Estal R; Palanca Suela S; de Juan Jiménez I; Egoavil Rojas C; García-Casado Z; Juan Fita MJ; Sánchez Heras AB; Segura Huerta A; Chirivella González I; Sánchez-Izquierdo D; Llop García M; Barragán González E; Bolufer Gilabert P Breast Cancer Res Treat; 2013 Nov; 142(1):19-30. PubMed ID: 24129975 [TBL] [Abstract][Full Text] [Related]
5. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Sánchez L; Rivas C; Benítez J Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3606-14. PubMed ID: 14506147 [TBL] [Abstract][Full Text] [Related]
7. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers. Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154 [TBL] [Abstract][Full Text] [Related]
8. DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. Flanagan JM; Cocciardi S; Waddell N; Johnstone CN; Marsh A; Henderson S; Simpson P; da Silva L; ; Khanna K; Lakhani S; Boshoff C; Chenevix-Trench G Am J Hum Genet; 2010 Mar; 86(3):420-33. PubMed ID: 20206335 [TBL] [Abstract][Full Text] [Related]
9. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations. Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397 [TBL] [Abstract][Full Text] [Related]
10. DNA damage response markers are differentially expressed in BRCA-mutated breast cancers. Aleskandarany M; Caracappa D; Nolan CC; Macmillan RD; Ellis IO; Rakha EA; Green AR Breast Cancer Res Treat; 2015 Feb; 150(1):81-90. PubMed ID: 25690937 [TBL] [Abstract][Full Text] [Related]
11. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient. Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424 [TBL] [Abstract][Full Text] [Related]
12. Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses. Wang Z; Zhang J; Zhang Y; Deng Q; Liang H Int J Mol Med; 2018 Dec; 42(6):3542-3550. PubMed ID: 30221688 [TBL] [Abstract][Full Text] [Related]
13. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Karp SE; Tonin PN; Bégin LR; Martinez JJ; Zhang JC; Pollak MN; Foulkes WD Cancer; 1997 Aug; 80(3):435-41. PubMed ID: 9241077 [TBL] [Abstract][Full Text] [Related]
14. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines. Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993 [TBL] [Abstract][Full Text] [Related]
15. Gene expression in inherited breast cancer. Hedenfalk IA; Ringnér M; Trent JM; Borg A Adv Cancer Res; 2002; 84():1-34. PubMed ID: 11883525 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures. Hedenfalk IA J Natl Cancer Inst; 2002 Jul; 94(13):960-1. PubMed ID: 12096075 [No Abstract] [Full Text] [Related]
17. Determination of molecular markers for BRCA1 and BRCA2 heterozygosity using gene expression profiling. Salmon AY; Salmon-Divon M; Zahavi T; Barash Y; Levy-Drummer RS; Jacob-Hirsch J; Peretz T Cancer Prev Res (Phila); 2013 Feb; 6(2):82-90. PubMed ID: 23341570 [TBL] [Abstract][Full Text] [Related]
18. PML protein expression in hereditary and sporadic breast cancer. Plevová P; Bouchal J; Fiurásková M; Foretová L; Navrátilová M; Zapletalová J; Curík R; Kubala O; Prokop J; Kolár Z Neoplasma; 2007; 54(4):263-8. PubMed ID: 17822314 [TBL] [Abstract][Full Text] [Related]
19. No association between BRCA mutations and sex ratio in offspring of Pakistani BRCA mutation carriers. Rashid MU; Torres D; Zaidi A; Rasheed F; Sultan F; Shakoori AR; Amin A; Hamann U Breast Cancer Res Treat; 2008 Jan; 107(1):155-6. PubMed ID: 18043900 [No Abstract] [Full Text] [Related]
20. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors. Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]